Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oral Cancer Drug Coverage Bill May Move In Combo With AWP Reform

Executive Summary

Sen. John Rockefeller (D-W.Va.) would like to tie a bill providing for Medicare coverage of oral cancer therapies with reform of the AWP reimbursement system for drugs already covered by Medicare

You may also be interested in...



Oral Cancer Drugs, MS Self-Injectables Covered In Medicare Pilot Program

The Medicare conference agreement sets aside $200 mil. to pay for oral cancer therapies under a demonstration project

Oral Cancer Drugs, MS Self-Injectables Covered In Medicare Pilot Program

The Medicare conference agreement sets aside $200 mil. to pay for oral cancer therapies under a demonstration project

OSI Developing Tarceva I.V. Formulation, Expected To Aid In Reimbursement

OSI Pharmaceuticals is developing an intravenous formulation of its investigational anticancer agent Tarceva, which should facilitate reimbursement for the investigational anticancer agent

Related Content

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel